Botulinum toxin and spasticity.
Davis
E C
EC
Barnes
M P
MP
D001905:Botulinum Toxins / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000150:complications; D017024:Chemotherapy, Adjuvant; D004599:Electric Stimulation Therapy; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D009465:Neuromuscular Agents / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000150:complications
D009465:Neuromuscular Agents; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A